Tecan uses cookies to improve our website. By continuing to browse our website, you accept our cookie policy.

This content is available also in other languages

x

This content is available also in other languages

April 29, 2010 | Customer News

Tecan collaborates with Arizona State University to rapidly assess radiation exposure

Tecan collaborates with Arizona State University to rapidly assess radiation exposure

Carl Yamashiro

 

Tecan is collaborating with Arizona State University (ASU) to develop the Integrated Biodosimetry System, a prototype robotic system for rapid, high throughput screening to measure an individual’s level of exposure to radiation in the event of a radiological or nuclear incident. The project, involving several prestigious organizations, is supported by the US Department of Health and Human Services’ Biomedical Advanced Research and Development Authority (BARDA), and focuses on development of a system to enable more rapid triage of patients than is currently possible. Tecan, the ASU Biodesign Institute and its partners hope to demonstrate proof-of-concept of the platform technology by the end of the current contract period.                                   

Dr Carl Yamashiro, principal investigator at ASU’s Biodesign Institute, explained: “The research team will work with Tecan on building a comprehensive high throughput system, allowing scientists to analyze blood samples from up to 2,000 people per day, per instrument. The beauty of our system is its versatility. Not only will we be developing a system for the effective response to a nuclear or radiological event that could affect a large population, but the high throughout platform can also be used to advance genomics testing and other routine laboratory procedures that measure gene expression levels.”

Peter Siesel, Vice President of Sales and Marketing at Tecan, said: “We are pleased and excited to be part of this impressive collaboration. Tecan has a long history of providing world-class automation solutions for our partners and customers. This project is especially important because of its significance to the defense and protection of the US population.”
 

About Tecan

Tecan (www.tecan.com) is a leading global provider of laboratory instruments and solutions in biopharmaceuticals, forensics, and clinical diagnostics. The company specializes in the development, production and distribution of instruments and automated workflow solutions for laboratories in the life sciences sector. With its subsidiary REMP (www.remp.com), Tecan is the market leader in automated laboratory storage and logistics systems. Its clients include pharmaceutical and biotechnology companies, university research departments, forensic and diagnostic laboratories. As an original equipment manufacturer, Tecan is also a leader in developing and manufacturing OEM instruments and components that are then distributed by partner companies. Founded in Switzerland in 1980, the company has manufacturing, research and development sites in both Europe and North America and maintains a sales and service network in 52 countries. In 2009, Tecan generated sales of CHF 392 million (USD 361.2 million; EUR 259.6 million). Registered shares of Tecan Group are traded on the SIX Swiss Exchange (TK: TECN/Reuters: TECZn.S/ ISIN CH0012100191).

 

Media contacts

Tecan Trading Ltd
Cornelia Kegele
Seestrasse 103
CH-8708 Männedorf

T +41 44 922 81 11
F +41 44 922 81 12